| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000044492 |
| Receipt No. | R000050633 |
| Scientific Title | Impact of a Smartphone App (NSER mobile) on the pre-hospital emergency care system. |
| Date of disclosure of the study information | 2021/06/10 |
| Last modified on | 2021/06/10 (Ver. 1) |
| Basic information | ||
| Public title | Impact of a Smartphone App (NSER mobile) on the pre-hospital emergency care system. | |
| Acronym | Impact of a Smartphone App (NSER mobile) on the pre-hospital emergency care system. | |
| Scientific Title | Impact of a Smartphone App (NSER mobile) on the pre-hospital emergency care system. | |
| Scientific Title:Acronym | Impact of a Smartphone App (NSER mobile) on the pre-hospital emergency care system. | |
| Region |
|
|
| Condition | ||
| Condition | Patients who are transferred by the emergency transport system | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the impact of a smartphone app (NSER mobile) on patiets' outcome and the pre-hospital emergency care system |
| Basic objectives2 | Others |
| Basic objectives -Others | To describe the number and rate of use of voice input or OCR technology |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | time required for patient transportation (time course before hospital arrival, especially from arrival at the scene to departure from the scene) |
| Key secondary outcomes | time required for data entry, number of cases refused for emergency transport, name of the disease at the time of transport, clinical outcome (admission, use of ventilator, and death), number and rate of use of voice input or OCR technology |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | All patients who were transported to Hitachi General Hospital by the emergency transport system from April 1, 2020 to March 31, 2022. | |||
| Key exclusion criteria | Patients who expresses their refusal to allow their clinical data to be used in research.
Patients who are judged by the principal investigator to be unsuitable as subjects. |
|||
| Target sample size | 10000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | TXP Medical Co. Ltd. | ||||||
| Division name | Clinical Research Division | ||||||
| Zip code | 113-8485 | ||||||
| Address | South Research Building, University of Tokyo, 252, 3-1, Hongo 7-chome, Bunkyo-ku, Tokyo, Japan | ||||||
| TEL | 08047907701 | ||||||
| keiliu0406@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | TXP Medical Co. Ltd. | ||||||
| Division name | Clinical Research Division | ||||||
| Zip code | 113-8485 | ||||||
| Address | South Research Building, University of Tokyo, 252, 3-1, Hongo 7-chome, Bunkyo-ku, Tokyo, Japan | ||||||
| TEL | 03-5615-8433 | ||||||
| Homepage URL | |||||||
| keibun.liu@txpmedical.com | |||||||
| Sponsor | |
| Institute | TXP Medical Co. Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Not applicable |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | TXP Medical Co. Ltd. |
| Address | South Research Building, University of Tokyo, 252, 3-1, Hongo 7-chome, Bunkyo-ku, Tokyo, Japan |
| Tel | 03-5615-8433 |
| txp-ethics@txpmedical.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | time required for patient transportation (time course before hospital arrival, especially from arrival at the scene to departure from the scene) |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050633 |